Lunch Session: Access to Medicines in Africa (Invitation only)

Supporting access to medicines and industrial development in Africa: Investing in domestic pharmaceutical manufacturing
in cooperation with UNAIDS, the African Union and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
Session Type
By invitation only
Room number
Green Room
21 July 2016
13:00 - 15:00 Africa/Nairobi

As a follow-up to the World Investment Forum 2014 session on investment in sustainable and universal access to medicines, this event will highlight political commitments and concrete business opportunities for expanding local production of pharmaceutical products in Africa and beyond, in order to promote access to medicines and related health commodities, particularly for scaling up access to HIV and TB testing and treatment. The event thereby seeks to support the new Sustainable Development Goals (SDGs), in particular SDG 3, SDG 9 and SDG 17.

Issues to be addressed

In order to improve the continent’s health security, African leaders have in recent years demonstrated important political commitment to support the local production of pharmaceutical products. One of the biggest challenges currently faced by African local pharmaceutical producers is how to meet requirements related to the quality, safety and efficacy of medicines and good manufacturing practices (GMP). This requires investment in quality upgrading. Access to credit is thus essential but domestic commercial banks are often hesitant to engage in long-term projects. Foreign investment and government support therefore play a major role in the promotion of local production of quality medicines and the transfer of GMP-related technologies and know-how. This event seeks to address the following issues:

  • The role of a coherent policy framework on health, trade, investment and intellectual property to attract foreign investors and promote domestic pharmaceutical production capacity
  • The identification of concrete business opportunities between local producers and potential investors


Director, Investment and Enterprise Division, UNCTAD
Secretary-General, UNCTAD
Executive Director, UNAIDS (represented by Abdoul Dieng, Chief of Policy Coordination and Programme Communication Office, UNAIDS)
Commissioner for Trade and Industry, African Union Commission
Minister of Health, Kenya
Minister of Trade and Industry
Minister of Health, Nigeria
Vice-President, West African Pharmaceutical Manufacturers Association and and CEO, Kinapharma Ltd., Ghana
Managing Director, Universal Corp. Ltd., Kenya
Secretary-General, Indian Pharmaceutical Alliance
Secretary General, China-Africa Business Council
Executive Director, Medicines Patent Pool
Professor of Economics, The Open University, United Kingdom
Country Director Kenya, UNAIDS
Managing Director, Impact Africa Capital, Uganda
Chair, German Generic Manufacturers Association (Pro Generika), Germany
Senior Policy Officer, Federal Ministry for Economic Cooperation & Development, Germany
Chairman, Deer Jet Medical Co. Ltd.
Legal Affairs and Trade Director, Medicines for Europe
Manager Policy Advocacy, Kenya Investment Authority
Writer, Intellectual Property Watch
Director, Government Pharmaceutical Organization, Thailand
Member, International Trade Committee, European Parliament
, Project Manager, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Germany
President, Bangladesh Association of Pharmaceutical Industries
PMPA Business Plan Coordinator, UNIDO, Austria
former UNCTAD Head of Branch, DIAE
Dutch United Nations Youth Representative